Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
James H. Litinsky, Chairman and CEO of MP Materials Corp. (MP), recently sold 185,167 shares of the company's common stock on June 3, 2026, generating approximately $12.8 million in proceeds. The sales were executed through a weighted average price range of $68.65 to $71.31 per share. Despite the executive's significant divestment, MP Materials rec…
Apogee Therapeutics, Inc. (NASDAQ: APGE) reported that Chief Medical Officer Carl Dambkowski sold 5,500 shares of common stock on June 3, 2026, for a total of $432,904. The transaction was executed at $78.71 per share and followed the exercise of options for 4,125 shares at $22.86 each. The sale was conducted under a Rule 10b5-1 trading plan adopte…
Northeast Community Bancorp (NECB) is a small-cap community bank trading below book and at a single-digit P/E after a solid Q1 that showed continued deposit inflows, disciplined credit and a growing construction loan pipeline. With strategic deposit restructuring lowering funding costs and a sizeable unfunded commitments backlog, NECB looks positio…
Blake Russell, Executive Vice President of Operations at Nexstar Media Group, Inc. (NASDAQ: NXST), executed a transaction involving the sale of 319 shares of the company's common stock. The sale, totaling $58,190, was necessitated by tax withholding requirements associated with the vesting of Restricted Stock Units (RSUs). This event coincides with…
Brett Jenkins, Executive Vice President and Chief Technology & Digital Officer at Nexstar Media Group, Inc. (NASDAQ: NXST), executed a sale of 397 shares of the company's common stock on June 4, 2026. The transaction, valued at approximately $72,418, was conducted to satisfy tax withholding requirements associated with the vesting of restricted sto…
Guardant Health Inc. (NASDAQ: GH) board member Steve Krognes executed a significant divestment of company shares on June 4, 2026, totaling $1,231,521. The transaction involved the sale of 9,294 shares of common stock, executed at prices ranging from $132.50 to $132.71, with a weighted average sale price of $132.5072. Following this transaction, Kro…
Dana Zimmer, President of Distribution & Strategy at Nexstar Media Group, Inc. (NASDAQ:NXST), sold 433 shares of the company's common stock on June 4, 2026. The transaction was valued at $78,985, executed at an average price of $182.4153 per share. The sale was specifically initiated to cover tax withholding obligations linked to the vesting of 938…
Entities linked to Brian N. Sheth, a director and significant shareholder of Blend Labs, Inc. (BLND), have acquired shares totaling $421,334 through Haveli Brooks Aggregator, L.P. The transactions occurred as the stock experienced a recent decline, trading at a discount to its fair value. This insider activity follows the company's mixed first-quar…
Andrew Alford, President of Broadcasting at Nexstar Media Group Inc. (NASDAQ:NXST), executed a sale of company shares on June 4, 2026, totaling $67,128. The transaction involved the disposition of 368 shares at a price of $182.4153 per share. According to Securities and Exchange Commission (SEC) filings, the sale was conducted to cover tax withhold…
CoreWeave, Inc. (NASDAQ: CRWV) Chief Strategy Officer Brian M. Venturo executed a series of stock transactions on June 3, 2026, resulting in the liquidation of approximately $13.05 million in company equity. The sale encompassed both directly held Class A Common Stock and shares converted from Class B Common Stock via West Clay Capital LLC, an enti…
MannKind Corporation announced new clinical and real-world data on Afrezza, its inhaled insulin product, at the ADA 2026 Scientific Sessions. The data build on the recent FDA approval for pediatric use and highlight Afrezza’s safety, efficacy, and patient treatment satisfaction in children, adolescents, and gestational diabetes patients. Additional…
Kailera Therapeutics and Hengrui Pharma announced encouraging clinical results for ribupatide, a GLP-1/GIP dual agonist, in both oral and injectable forms for obesity treatment. Phase 2 data from Hengrui showed up to 12.1% mean weight loss with the oral pill over 26 weeks with favorable tolerability. Kailera's Phase 1 trial of the injection demonst…
Biomea Fusion presented promising clinical and translational data for its oral menin inhibitor icovamenib at the ADA 86th Scientific Sessions, demonstrating benefits in type 1 and type 2 diabetes including improved insulin secretion, glycemic control, muscle preservation, and fat reduction. Additionally, the company announced expansion of its Phase…
Brian M. Venturo, CoreWeave's Chief Strategy Officer and director, executed a sale of 15,385 Class A Common Stock shares on June 3, 2026, generating $1,730,905. The transaction, facilitated by the Venturo Family GST Exempt Trust under a Rule 10b5-1 plan adopted in late 2025, includes the conversion of equivalent Class B shares. Following this activ…
Eastern Co (NASDAQ:EML) director Frederick D. DiSanto has acquired an additional 213 shares of the company's common stock, bringing his direct holdings to 101,068 shares. The transaction occurred on June 4, 2026, at a price of $21.50 per share, totaling $4,579. This purchase adds to his existing indirect beneficial ownership through entities linked…
Zachary M. Briers, General Counsel at Snap Inc., has executed a sale of 11,958 shares of the company’s Class A Common Stock on June 4, 2026, under a pre-arranged trading plan. The transaction, valued at $71,748, occurred at a price of $6.00 per share, slightly above the stock's recent trading level of $5.76. This divestment follows a period of sign…
Western Digital Corp (NASDAQ: WDC) Chief Legal Officer and Corporate Secretary Cynthia L. Tregillis recently executed a series of stock transactions, including a significant sale under a Rule 10b5-1 trading plan and additional disposals tied to tax withholdings and vesting events. These transactions occur against the backdrop of the company's stron…
Dillard’s, Inc. (NYSE:DDS) director J.C. Watts Jr. executed a significant stock sale, divesting 400 shares of Class A common stock on June 5, 2026. The transaction, valued at $243,671, follows a period of substantial stock appreciation for the retailer. Despite recent robust earnings performance and consistent dividend increases, market analysts co…
Philip Ryan Barros Sr., Chief Executive Officer of Ichor Holdings, Ltd. (NASDAQ: ICHR), executed a significant divestment of company stock on June 4, 2026, selling 13,705 ordinary shares for a total of $961,953. The transactions were facilitated through a Rule 10b5-1 trading plan established earlier in the year, with the shares sold at prices rangi…
Christopher D. Brown, a director at 908 Devices Inc. (NASDAQ: MASS), sold 100 shares of the company's common stock on June 4, 2026. The transaction was executed under a Rule 10b5-1 trading plan established on November 24, 2025. Following the sale, Brown retains direct ownership of 875,459 shares. The sale price of $9.00 per share occurred as the st…
Biglari Holdings Inc. (NYSE:BH) Chairman and CEO Sardar Biglari has directed his affiliated investment vehicle, The Lion Fund, L.P., to acquire additional shares of the company's Class B common stock. The purchases, totaling approximately $658,792, were executed over two days in early June 2026. This insider activity occurs against a backdrop of a …
Suma Krishnan, President of Research & Development at Krystal Biotech, Inc. (NASDAQ:KRYS), executed a sale of 25,000 shares of company common stock on June 4, 2026, totaling approximately $7,702,825. The transactions were carried out under a Rule 10b5-1 trading plan established in September 2025 and activated in December 2025, with a scheduled conc…
Krish S. Krishnan, President and CEO of Krystal Biotech, Inc. (NASDAQ:KRYS), executed a sale of 25,000 shares valued at approximately $7.7 million on June 4, 2026. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan established in September 2025. This sale occurs as Krystal Biotech's shares trade near their 52-week high of $…
nLIGHT Inc. (NASDAQ: LASR) President and CEO Scott H. Keeney has executed a series of stock sales totaling approximately $1.89 million, according to recent regulatory filings. The transactions, which involved both tax-related liquidations and pre-arranged sales, occur against a backdrop of robust financial performance for the laser technology compa…
nLIGHT Inc. (NASDAQ: LASR) Chief Financial Officer Joseph John Corso has completed two separate stock sales totaling $577,740 in early June 2026. The transactions were driven by tax obligations on vesting restricted stock units and a pre-existing trading plan. This activity follows a period of significant price appreciation for the company and coin…
